Rationale to combine with classical or novel therapies

Date 10 September 2017
Event ESMO 2017 Congress
Session Immunotherapy in head and neck cancer
Topics Cytotoxic agents
Immunotherapy
Head and Neck Cancers
Therapy
Biological therapy
Presenter Amanda Psyrri
Authors A. Psyrri
  • Internal Medicine/medical Oncology, Attikon University Hospital, 12462 - Athens/GR